Urinary CFHR2 as a Biomarker for Early Diagnosis and DiseaseProgression Prediction in Diabetic Kidney Disease

CFHR2 has satisfactory potential to be a biomarker for early diagnosis and risk of progression of DKD.

Authors

Institutions

Publication Details

Journal
Current Molecular Medicine
Published
2025-05-26
DOI
https://doi.org/10.2174/0115665240350524250524065114
Primary Topic
Chronic Kidney Disease and Diabetes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Urinary CFHR2 as a Biomarker for Early Diagnosis and DiseaseProgression Prediction in Diabetic Kidney Disease

Qing Zhang, Tao Du
Current Molecular Medicine
Chronic Kidney Disease and Diabetes
article

Urinary CFHR2 as a Biomarker for Early Diagnosis and DiseaseProgression Prediction in Diabetic Kidney Disease

Qing Zhang, Tao Du
article en

Abstract

CFHR2 has satisfactory potential to be a biomarker for early diagnosis and risk of progression of DKD.

Current Molecular MedicineVol. 25
Mianyang Third People's Hospital (CN), Sichuan Mianyang 404 Hospital (CN)
Good health and well-being
Openalex Percentile: Top 86%
Chronic Kidney Disease and Diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Urinary CFHR2 as a Biomarker for Early Diagnosis and DiseaseProgression Prediction in Diabetic Kidney Disease — Qing Zhang, Tao Du · Current Molecular Medicine (2025) | TGRS Research Map | TGRS